Immunology Market Access Lead — Strategy & Projects

705 Lilly USA, LLC; Indianapolis (IN); Presencial; USD 167 000 - 244 000; Tempo integral

Vantagens oferecidas por esta oferta de emprego

401(k) plan

Pension

Vacation benefits

Well-being benefits

Resumo da oferta

Lilly in Indianapolis, IN, is seeking a Market Access Special Project Leader to advance Immunology access initiatives across launch operations, pricing, affordability, and provider tools. You’ll lead cross‑functional teams, shape payer strategy, and deliver measurable access solutions from scope to results in a fast-paced environment.

Highlights include partnering with brand and field teams, aligning with LVA and PRA leaders, and driving cross‑portfolio opportunities while protecting

Qualificações

• Bachelor’s degree 5+ years of PRA, US Commercial Strategy, Channel, or Patient Reimbursement experience.
• PRA and channel expertise: deep knowledge of specialty pharmacy, hub, payer and health system channels.
• Launch experience: led market access work for a launch, ideally with PRA launch teams.

Responsabilidades

• Support launch operations across the Immunology portfolio and build channel strategy for new indications, age groups and dose forms.
• Set clear solutions for denied or blocked claims and partner with Lilly teams to start therapy without delay.
• Lead US payer strategy and engagement for emerging portfolio opportunities and cross-portfolio initiatives.

Conhecimentos

PRA expertise

Channel strategy

Market access

Launch experience

Data fluency

Communication skills

Cross-functional collaboration

Formação académica

Bachelor’s degree

Descrição da oferta de emprego

Lilly in Indianapolis, IN, is seeking a Market Access Special Project Leader to advance Immunology access initiatives across launch operations, pricing, affordability, and provider tools. You’ll lead cross‑functional teams, shape payer strategy, and deliver measurable access solutions from scope to results in a fast-paced environment.

Highlights include partnering with brand and field teams, aligning with LVA and PRA leaders, and driving cross‑portfolio opportunities while protecting